Uterine tumor resembling ovarian sex cord tumor: Report of a case with t(X;6)(p22.3;q23.1) and t(4;18)(q21.1;q21.3)

Diagnostic Molecular Pathology

Volumn 12, Issue 3, 2003, Pages 174-180

  Wang, Jianzhou ^a,d   Blakey, Gregory L ^a   Zhang, Lijun ^a   Bane, Barbara ^a   Torbenson, Michael ^b,c   Li, Shibo ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b Center for Advanced Diagnostics   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Ameripath Inc   (United States)

Author keywords

Cytogenetics; Uterine tumor; Uterine tumor resembling ovarian sex cord tumor

Indexed keywords

ACTIN; CD99 ANTIGEN; CYTOKERATIN; ESTROGEN RECEPTOR; GENE PRODUCT; PROGESTERONE RECEPTOR; PROTEIN BCL 2; VIMENTIN;

ADULT; ARTICLE; CARCINOGENESIS; CASE REPORT; CHROMOSOME 4; CHROMOSOME TRANSLOCATION; CLINICAL FEATURE; CYTOGENETICS; FEMALE; GENE TRANSLOCATION; GONADAL DEVELOPMENT RELATED GENE; H Y REGULATOR GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; ONCOGENE; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATOR GENE; SEX CORD TUMOR; UTERINE TUMOR RESEMBLING OVARIAN SEX CORD TUMOR; UTERUS TUMOR; X CHROMOSOME;

EID: 0042889182     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-200309000-00009     Document Type: Article

References (35)

1. Langley FA, Smith JP, Woodcock AS. Debatable uterine tumors. Acta Obstet Gynaecol Scand. 1953;32:143-169.
2. Morehead RP, Bowman MC. Heterologous mesodermal tumors of the uterus: report of a case resembling a granulosa cell tumor. Am J Pathol. 1945;21:53-61.
3. Clement PB, Scully RE. Uterine tumors resembling ovarian sex-cord tumors: a clinicopathologic analysis of fourteen cases. Am J Clin Path. 1976;66:512-525.
4. Baker RJ, Hildebrandt RH, Rouse RV, et al. Inhibin and CD99 (MIC2) expression in uterine stromal neoplasms with sex-cord-like elements. Hum Pathol. 1999;30:671-679.
5. Fukunaga M, Miyazawa Y, Ushigome S. Endometrial low-grade stromal sarcoma with ovarian sex cord-like differentiation: report of two cases with an immunohistochemical and flow cytometric study. Path Int. 1997;47:412-415.
6. Hauptmann S, Nadjari B, Kraus J, et al. Uterine tumor resembling ovarian sex-cord tumor-a case report and review of the literature. Virchows Arch. 2001;439:97-101.
7. Krishnamurthy S, Jungbluth AA, Busam KJ, et al. Uterine tumors resembling ovarian sex-cord tumors have an immunophenotype consistent with true sex-cord differentiation. Am J Surg Path. 1998;22:1078-1082.
8. McCluggage WG. Uterine tumours resembling ovarian sex cord tumors: immunohistochemical evidence for true sex cord differentiation. Histopathology. 1999;34:375-376.
9. Blaakkaer J, Micic S, Morris ID, et al. Immunoreactive inhibin production in post-menopausal women with malignant epithelial tumors. Eur J Obsttet Gynecol Reprod Bio. 1993;52:105-110.
10. Flemming P, Wellmann A, Maschek H, et al. Monoclonal antibodies against inhibin represent key markers of adult granulosa cell tumors of the ovary even in their metastases. A report of three cases with late metastasis being previously misinterpreted as hemagiopericytoma. Am J Surg Path. 1995;19:927-933.
11. Loo KT, Leung AKF, Chan JKC. Immunohistochemical staining of ovarian granulosa cell tumors with MIC2 antibody. Histopathology. 1995;27:388-390.
12. Stevenson AJ, Chatten J, Bertoni F, et al. CD99(p30/32mic2) neuroectodermal/Ewings sarcomas antigen as an immunohistochemical marker: review of more than 600 tumors and the literature experience. Appl Immunohistochem. 1994;22:31-40.
13. Stewart CJR, Jeffers MD, Kennedy A. Diagnostic value of inhibin immunoreactivity in ovarian gonadal stromal tumors and histologic mimics. Histopathology. 1997;31:67-74.
14. Clement PB, Young RH. Mesenchymal and mixed epithelial-mesenchymal tumors of the uterine corpus and cervix. In: Clement PB and Young RH, eds. Atlas of Gynecologic SurgicalPpathology. Philadelphia, PA: W.B. Saunders Company, 2000:206-207.
15. Munemitsu S, Albert I, Souza B, et al. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci U S A. 1995;92:3046-3050.
16. Rubinfeld B, Albert I, Porfiri E, et al. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science. 1996;272:1023-1026.
17. Kuhnen C, Herter P, Muller O, et al. Beta-catenin in soft tissue sarcomas: expression is related to proliferative activity in high-grade sarcomas. Mod Pathol. 2000;13:1005-1013.
18. Morin PJ, Sparks AB, Korinek V, et al. Activation of beta-catenin-Tcf singaling in colon cancer by mutations in beta-catenin of APC. Science. 1997;275:1787-1790.
19. Palacios J, Gamallo C. Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Cancer Res. 1998;58:1344-1347.
20. Sparks AB, Morin PJ, Vogelstein B, et al. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res. 1998;58:1130-1134.
21. Gil-Benso R, Lopez-Gines C, Navarro S, et al. Endometrial stromal sarcomas: immunohistochemical, electron microscopical and cytogenetic findings in two cases. Virchows Arch. 1999;434:307-314.
22. Iliszko M, Mandahl N, Mrozek K, et al. Cytogenetics of uterine sarcomas: Presentation of eight new cases and review of the literature. Gynecol Oncol. 1998;71:172-176.
23. Pauwels P, Dak Cin P, Van De Moosdijk CNF, et al. Cytogenetics revealing the diagnosis in a metastatic endometrial stromal sarcoma. Histopathology. 1996;29:84-87.
24. Kitada S, Pederson IM, Schimmer AD, et al. Dysregulation of apoptosis genes in hematopoietic malignancies. Oncogene. 2002;21:3459-3474.
25. Ngan B, Chen-Levy Z, Weiss LM, et al. Expression in non-Hodgkin's lymphoma of the bcl-2 protien associated with the t(14;18) chromosomal translocation. NEJM. 1988;318:1638-1644.
26. Sliverman GA, Bartuski AJ, Cataltepe S, et al. SCCA1 and SCCA2 are proteinase inhibitors that map to serpin cluster at 18q21.3. Tumour Biol. 1998;19:480-487.
27. Stenman J, Hedstrom J, Grenman R, et al. Relative levels of SCCA2 and SCCA1 mRNA in primary tumors predicts recurrent disease in squamous cell cancer of the head and neck. Int J Cancer. 2001;95:39-43.
28. Mellen P, Rabizadeh S, Snipas SJ, et al. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature. 1998;22:801-804.
29. Chen CS, Bejcek BE, Kersey JH. A Mapping study of 13 genes on human chromosome bands 4q11-25. Cytogenet Cell Genet. 1995;69:260-265.
30. Wolf U, Fraccaro M, Mayerova A. A gene controlling H-Y antigen on the X chromosome: tentative assignment deletion mapping to Xp22.3. Hum Genet. 1980;54:149-154.
31. Wolf U. The serologically detected H-Y antigen revisited. Cytogenet Cell Genet. 1988;80:232-235.
32. Nagai Y, Ciccarese S, Ohno S. The identification of human H-Y antigen and testicular transformation induced by its interaction with the receptor site of bovine fetal ovarian cells. Differentiation. 1979;13:155-164.
33. Bernstein R, Koo GC, Wachtel SS. Abnormalities of the X-chromosome in 46, XY females sibs with ovaries. Science. 1980;207:768-769.
34. Mann JR, Corkery JJ, Fisher HJW, et al. The X linked recessive form of XY gonadal dysgenesis with a high incidence of gonadal germ cell tumours: clinical and genetic studies. J Med Gene. 1983;20:264-270.
35. Nichter LS. Seminoma in a 46,XX true hermaphrodite with positive H-Y antigen. Cancer. 1984;53:1181-1184.